Cargando…
Necroptosis in Immuno-Oncology and Cancer Immunotherapy
Immune-checkpoint blockers (ICBs) have revolutionized oncology and firmly established the subfield of immuno-oncology. Despite this renaissance, a subset of cancer patients remain unresponsive to ICBs due to widespread immuno-resistance. To “break” cancer cell-driven immuno-resistance, researchers h...
Autores principales: | Sprooten, Jenny, De Wijngaert, Pieter, Vanmeerbeek, Isaure, Martin, Shaun, Vangheluwe, Peter, Schlenner, Susan, Krysko, Dmitri V., Parys, Jan B., Bultynck, Geert, Vandenabeele, Peter, Garg, Abhishek D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464343/ https://www.ncbi.nlm.nih.gov/pubmed/32752206 http://dx.doi.org/10.3390/cells9081823 |
Ejemplares similares
-
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
por: Vanmeerbeek, Isaure, et al.
Publicado: (2020) -
The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology
por: Vanmeerbeek, Isaure, et al.
Publicado: (2022) -
A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology
por: Sprooten, Jenny, et al.
Publicado: (2022) -
Trial watch: chemotherapy-induced immunogenic cell death in oncology
por: Sprooten, Jenny, et al.
Publicado: (2023) -
The emergence of phox-ER stress induced immunogenic apoptosis
por: Garg, Abhishek D., et al.
Publicado: (2012)